Form 4 for NMTC NEUROONE MEDICAL TECHNOLOGIES Corp
Accepted 2023-04-25 00:00:00 ET · period of report 2023-04-21 · accession 0001540354-23-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-04-25 | 2023-04-21 | NMTC | Rosa David A | CEO, Pres, Dir | A - Grant | $0.00 | +91.5K | 550.1K | +20% | $0 |
| D | 2023-04-25 | 2023-04-21 | NMTC | Rosa David A | CEO, Pres, Dir | A - Grant | $0.00 | +91.5K | 91.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-21 | A | A | 91,500 | $0.00 | 550,119 | D | — | — | (F1) Represents a grant of restricted stock units, which vest as to 50% of the shares on the first anniversary of the grant date, with the remaining shares vesting in equal quarterly installments on the last day of each quarter over the next 8 quarters, subject to continued service on such vesting date. |
| 2 | Derivative | Option to Purchase Common Stock | 2023-04-21 | A | A | 91,500 | $0.00 | 91,500 | D | $1.59 · — to 2033-04-20 | 91,500 Common Stock | (F2) 25% will vest on April 21, 2024 and the remaining 75% will vest in 12 equal quarterly installments on the last day of each quarter beginning on June 30, 2024. |